Yüklüyor......
Mutant p53 in cancer therapy—the barrier or the path
Since wild-type p53 is central for maintaining genomic stability and preventing oncogenesis, its coding gene TP53 is highly mutated in ~50% of human cancers, and its activity is almost abrogated in the rest of cancers. Approximately 80% of p53 mutations are single point mutations with several hotspo...
Kaydedildi:
| Yayımlandı: | J Mol Cell Biol |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Oxford University Press
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6487791/ https://ncbi.nlm.nih.gov/pubmed/30508182 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jmcb/mjy072 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|